FCM
EMN icon

Fieldview Capital Management’s Eastman Chemical EMN Stock Holding History

Fieldview Capital Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,731
Closed -$428K – 432
2025
Q2 		$428K Sell
5,731
-25,392
-82% -$2M 0.06% 266
2025
Q1 		$2.74M Buy
+31,123
New +$2.94M 0.39% 97

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fieldview Capital Management's EMN Position: Q3 2025 in Review

Fieldview Capital Management sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 5,731 shares — an estimated $428K sold.

Fieldview Capital Management first reported a position in EMN in Q1 2025 and held it in 2 quarters. The position peaked at $2.74M in Q1 2025. 664 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

  • Fieldview Capital Management reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 5,731 Eastman Chemical shares in Q3 2025, an estimated $428K.
  • Fieldview Capital Management first reported a position in Eastman Chemical in Q1 2025 and held it in 2 quarters.
  • Fieldview Capital Management's Eastman Chemical position peaked at $2.74M in Q1 2025.
  • 664 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Fieldview Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.